408 related articles for article (PubMed ID: 12451568)
1. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
[TBL] [Abstract][Full Text] [Related]
4. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
5. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
Holladay EB; Logan S; Arnold J; Knesel B; Smith GD
Cancer; 2006 Dec; 108(6):451-61. PubMed ID: 17078096
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
8. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of p16 in anal cytology specimens: histologic correlation.
Darvishian F; Stier EA; Soslow RA; Lin O
Cancer; 2006 Feb; 108(1):66-71. PubMed ID: 16404747
[TBL] [Abstract][Full Text] [Related]
10. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
11. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
12. p16INK4A expression in cervical premalignant and malignant lesions.
Lambert AP; Anschau F; Schmitt VM
Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method.
Moore GD; Lear SC; Wills-Frank LA; Martin AW; Snyder JW; Helm CW
Diagn Cytopathol; 2005 Feb; 32(2):82-7. PubMed ID: 15637682
[TBL] [Abstract][Full Text] [Related]
14. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia.
Wentzensen N; Bergeron C; Cas F; Vinokurova S; von Knebel Doeberitz M
Cancer; 2007 Feb; 111(1):58-66. PubMed ID: 17186505
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
16. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens.
Bibbo M; Klump WJ; DeCecco J; Kovatich AJ
Acta Cytol; 2002; 46(1):25-9. PubMed ID: 11843554
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.
Dehn D; Torkko KC; Shroyer KR
Cancer; 2007 Feb; 111(1):1-14. PubMed ID: 17219448
[TBL] [Abstract][Full Text] [Related]
18. p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women.
Missaoui N; Trabelsi A; Hmissa S; Fontanière B; Yacoubi MT; Mokni M; Korbi S; Frappart L
Pathol Res Pract; 2010 Aug; 206(8):550-5. PubMed ID: 20400236
[TBL] [Abstract][Full Text] [Related]
19. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.
Guo M; Hu L; Baliga M; He Z; Hughson MD
Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
